U.S. Banks Stock News

STAAR Surgical reported past first-quarter 2026 results with net sales of US$93.52 million, a very large increase from US$42.59 million a year earlier, and moved from a net loss to net income of US$5.21 million. The quarter underscored how resurgent demand in China for EVO+ lenses, combined with expanding U.S. indications and tighter cost control, has transformed the company’s profitability profile. We’ll now examine how this sharp earnings rebound, powered by EVO+ lens demand in China,...

Recent performance and why GCI Liberty is on investors’ radar GCI Liberty (GLIB.A) has drawn fresh attention after a period of weaker share performance, with the stock down about 32% over the past month and 35% over the past 3 months. See our latest analysis for GCI Liberty. With the share price at US$25.59 and short term share price returns of 10.9% over the past week and 32.4% over the past month, recent weakness has added to a year to date share price decline of 28.6%. This suggests...

Perimeter Solutions (PRM) has drawn fresh attention after first quarter 2026 results showed sales of US$125.07 million and net income of US$72.94 million, along with a renewed emphasis on acquisitions and disciplined capital deployment. See our latest analysis for Perimeter Solutions. The earnings and acquisition comments have landed after a strong run in the stock, with a 30 day share price return of 19.53% and a 1 year total shareholder return of 181.13%, suggesting that momentum has been...

Nurix Therapeutics (NRIX) is back in focus after reporting new preclinical and Phase 1 data for its BTK degrader NX-5948, and after securing an oral presentation slot at the European Hematology Association Congress. See our latest analysis for Nurix Therapeutics. Despite the recent NX-5948 data and the upcoming European Hematology Association presentation, Nurix Therapeutics’ share price has eased over the past month, with a 30 day share price return of 9.45% down, even as the 1 year total...

The Chemours Company recently reported first quarter 2026 results, with sales of US$1,381 million and a net loss of US$29 million, while also affirming a quarterly cash dividend of US$0.0875 per share. At the same time, Chemours issued new guidance calling for sequential net sales growth in the second quarter of 2026 and full‑year 2026 net income attributable to the company between US$165 million and US$225 million, framing a clearer profitability path after a period of losses. Now we’ll...

National Health Investors, Inc. reported past first-quarter 2026 results with sales of US$73.15 million, total revenue of US$115.13 million, and net income of US$40.10 million, while also declaring a second-quarter dividend of US$0.92 per common share payable on August 7, 2026. Importantly, management also issued full-year 2026 net income guidance of about US$703.00 million to US$705.20 million, giving investors a clearer view of expected profitability. Next, we’ll examine how this higher...

As you might know, SBC Medical Group Holdings Incorporated ( NASDAQ:SBC ) just kicked off its latest first-quarter...

The subdued market reaction suggests that Uber Technologies, Inc.'s ( NYSE:UBER ) recent earnings didn't contain any...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see CNH...

The market shrugged off Nu Skin Enterprises, Inc.'s ( NYSE:NUS ) solid earnings report. We did some digging and believe...

U.S. Physical Therapy, Inc. ( NYSE:USPH ) is about to trade ex-dividend in the next three days. The ex-dividend date is...

It looks like Valero Energy Corporation ( NYSE:VLO ) is about to go ex-dividend in the next two days. The ex-dividend...

The York Water Company's ( NASDAQ:YORW ) robust recent earnings didn't do much to move the stock. We think this is due...

We wouldn't blame Pinnacle West Capital Corporation ( NYSE:PNW ) shareholders if they were a little worried about the...

CVS Health Corporation's ( NYSE:CVS ) stock was strong despite it releasing a soft earnings report last week. However...

Mach Natural Resources LP recently reported first-quarter 2026 results, with average production of 158 Mboe/d, revenue of US$285.93 million, and a net loss of US$35.04 million, while declaring a quarterly cash distribution of US$0.64 per common unit to be paid on June 4, 2026. The combination of higher revenue but a move to a loss, alongside maintaining a cash distribution, highlights the tension between Mach’s capital needs and its commitment to unitholder payouts. We’ll now examine how...

ICL Group (NYSE:ICL) is back in focus after first quarter 2026 results showed sales of US$2,023 million and net income of US$126 million, along with a higher dividend and raised EBITDA guidance. See our latest analysis for ICL Group. ICL Group's recent first quarter update and higher dividend come after a 22.33% 1 month share price return and 10.71% year to date share price return, while the 1 year total shareholder return is slightly negative, suggesting momentum has picked up recently after...

AvePoint earnings jump and higher revenue guidance put Q1 performance in focus AvePoint (AVPT) is back on investor radars after reporting first quarter revenue of US$117.24 million and net income of US$15.25 million, along with higher revenue guidance for both the second quarter and full year 2026. See our latest analysis for AvePoint. The earnings beat, higher revenue guidance and progress on the buyback have arrived against a weak share price backdrop, with AvePoint’s stock down 24.9% year...

Over the last 7 days, the United States market has remained flat, yet it has experienced a notable 24% rise over the past year with earnings expected to grow by 17% annually in the coming years. In this context, identifying small-cap stocks that are undervalued and show signs of insider buying can be a strategic approach for investors seeking opportunities that align with these market dynamics.

In the last week, the market has stayed flat, yet it is up 24% over the past year with earnings forecasted to grow by 17% annually. In such a vibrant market environment, identifying undervalued stocks can provide investors with opportunities to capitalize on potential growth at a discounted price.

Over the last 7 days, the United States market has remained flat, yet it has experienced a notable rise of 24% over the past year, with earnings projected to grow by 17% annually in the coming years. In this context of steady market performance and promising growth expectations, identifying stocks with high insider ownership can be a key factor for investors seeking companies where management's interests are closely aligned with those of shareholders.

Over the last 7 days, the United States market has remained flat, but it has risen 24% over the past 12 months with earnings forecasted to grow by 17% annually. For investors willing to explore beyond well-known companies, penny stocks—often representing smaller or newer entities—can present unexpected opportunities. Despite their vintage name, these stocks can still provide surprising value and potential for growth when backed by solid financial foundations.

The United States market remained flat over the last week but has seen a 24% increase over the past year, with earnings forecast to grow by 17% annually. In this context, dividend stocks can be an attractive option for investors seeking steady income and potential growth in a dynamic market environment.

Soft earnings didn't appear to concern Cadre Holdings, Inc.'s ( NYSE:CDRE ) shareholders over the last week. We think...